Based on the provided data, I cannot extract specific medications or therapies as the source information does not contain details about the treatments used in the trial. While the trial title indicates it’s a multi-arm study for evaluating drug efficacy in ALS patients, the specific medications are not listed in the provided data. The trial appears to be comparing multiple drugs against placebo for survival outcomes in ALS patients, but without the actual medication names being specified, I cannot provide descriptions of the treatments involved.

Amyotrophic Lateral Sclerosis (ALS) – A progressive neurological disease that affects nerve cells responsible for controlling voluntary muscle movement. The disease causes the death of motor neurons, which leads to the brain losing its ability to initiate and control muscle movement. Over time, patients experience gradual weakening of muscles used for activities like walking, speaking, swallowing, and breathing. The condition typically begins with muscle twitching, weakness in a limb, or slurred speech. As motor neurons continue to die, the muscles progressively weaken and begin to atrophy. The disease affects different people in different ways, with varying patterns of progression.